These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 16428924)

  • 1. Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome.
    Venkatapuram S; Shannon RP
    Am J Ther; 2006; 13(1):64-71. PubMed ID: 16428924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
    Bestermann W; Houston MC; Basile J; Egan B; Ferrario CM; Lackland D; Hawkins RG; Reed J; Rogers P; Wise D; Moore MA
    Am J Med Sci; 2005 Jun; 329(6):292-305. PubMed ID: 15958871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
    Hoerger TJ; Ahmann AJ
    J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M; Goya K; Kasayama S
    Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the metabolic syndrome as a strategy for preventing the macrovascular complications of type 2 diabetes: controversial issues.
    Aguilar-Salinas CA; Mehta R; Rojas R; Gómez-Pérez FJ; Olaiz G; Rull JA
    Curr Diabetes Rev; 2005 May; 1(2):145-58. PubMed ID: 18220590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
    Srikanth S; Deedwania P
    Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hypertension in children and adolescents with the metabolic syndrome.
    Puri M; Flynn JT
    J Cardiometab Syndr; 2006; 1(4):259-68. PubMed ID: 17679805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome: cardiovascular risk assessment and management.
    Wong ND
    Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic syndrome].
    Boursier V
    J Mal Vasc; 2006 Sep; 31(4 Pt 1):190-201. PubMed ID: 17088787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for the management of atherosclerotic diseases in diabetes mellitus].
    Kotake H; Oikawa S
    Nihon Rinsho; 2006 Nov; 64(11):2074-80. PubMed ID: 17087299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in people with diabetes and the metabolic syndrome: pathophysiologic insights and therapeutic update.
    Ganne S; Arora SK; Dotsenko O; McFarlane SI; Whaley-Connell A
    Curr Diab Rep; 2007 Jun; 7(3):208-17. PubMed ID: 17547838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for special populations: diabetes mellitus and the metabolic syndrome.
    Sowers JR
    Am J Hypertens; 2003 Nov; 16(11 Pt 2):41S-45S. PubMed ID: 14625160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is type-2 diabetes mellitus preventable?].
    Jermendy G
    Orv Hetil; 2003 Sep; 144(39):1909-17. PubMed ID: 14598569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications.
    Meerarani P; Badimon JJ; Zias E; Fuster V; Moreno PR
    Curr Mol Med; 2006 Aug; 6(5):501-14. PubMed ID: 16918371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment principles for the metabolic syndrome].
    Boulogne A; Vantyghem MC
    Presse Med; 2004 Jun; 33(10):673-81. PubMed ID: 15257242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimisation of the management of patients with coronary heart disease and type 2 diabetes mellitus.
    Wilson SH; Kennedy FP; Garratt KN
    Drugs Aging; 2001; 18(5):325-33. PubMed ID: 11392441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary.
    ; ; Grundy SM; Cleeman JI; Daniels SR; Donato KA; Eckel RH; Franklin BA; Gordon DJ; Krauss RM; Savage PJ; Smith SC; Spertus JA; Costa F
    Cardiol Rev; 2005; 13(6):322-7. PubMed ID: 16708441
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing macrovascular disease in patients with type 2 diabetes mellitus.
    Johansen OE; Birkeland KI
    Am J Cardiovasc Drugs; 2003; 3(4):283-97. PubMed ID: 14728081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.